Article

Segment 1 - Immuno-Oncology Education Outreach Efforts

Surabhi Dangi-Garimella, PhD, managing editor of The American Journal of Managed Care's Evidence-Based series led the panel of experts in a discussion on immuno-oncology by first talking about checkpoint inhibitors currently in the market and under development.

Surabhi Dangi-Garimella, PhD, managing editor of The American Journal of Managed Care’s Evidence-Based series led the panel of experts in a discussion on immuno-oncology by first talking about checkpoint inhibitors currently in the market and under development.

Kimberly Shafer-Weaver, PhD, explained that in order to keep providers and patients more aware of the latest developments, there needs to be a better outreach effort at meetings and other venues to educate people about immunotherapists and how they can be used.

Related Videos
Nini Wu, MD, Navista
CK Wang, MD, COTA
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Pieter Sonneveld, MD, PhD
Naim Alkhouri, MD
Antoine Keller, MD
Pieter Sonneveld, MD, PhD
Dr K. Vish Viswanath
Lalan Wilfong, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo